Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2000 December;42(4) > Panminerva Medica 2000 December;42(4):287-91

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

PANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6


eTOC

 

CASE REPORTS  


Panminerva Medica 2000 December;42(4):287-91

Copyright © 2009 EDIZIONI MINERVA MEDICA

lingua: Inglese

Management strategies in resection for carcinoma of the hepatic duct confluence: how to increase the resectability rate. Our experience and literature review

Leone N., De Paolis P. *, Carrera M. *, Pellicano R., Actis G. C., Fronda G. R. *, Rizzetto M.

From the Department of Gastroenterology
*B Surgery Molinette Hospital, Turin, Italy


PDF  


The resect­ability ­rate of ­hilar ­bile ­duct car­ci­noma is ­reported to be var­i­able and to ­inversely cor­re­late ­with the ­size of the asso­ciated ­liver resec­tion. In an ­attempt to ­reduce the ­risk of post­op­er­a­tive ­liver ­failure, the induc­tion of a hyper­trophy of rem­nant ­liver by pre­op­er­a­tive ­portal ­vein embol­iza­tion (PVE) has ­been pro­posed. We ­hereby ana­lyse the ­results and the tech­nical ­aspects of ­this pro­ce­dure ­along ­with our per­sonal expe­ri­ence.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail